Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, July 2, 2021
[ Fri, Jul 02nd 2021
] - WOPRAI
[ Fri, Jul 02nd 2021
] - WOPRAI
[ Fri, Jul 02nd 2021
] - WOPRAI
[ Fri, Jul 02nd 2021
] - WOPRAI
[ Fri, Jul 02nd 2021
] - WOPRAI
[ Fri, Jul 02nd 2021
] - WOPRAI
[ Fri, Jul 02nd 2021
] - WOPRAI
[ Fri, Jul 02nd 2021
] - WOPRAI
[ Fri, Jul 02nd 2021
] - WOPRAI
[ Fri, Jul 02nd 2021
] - WOPRAI
[ Fri, Jul 02nd 2021
] - WOPRAI
[ Fri, Jul 02nd 2021
] - WOPRAI
[ Fri, Jul 02nd 2021
] - WOPRAI
[ Fri, Jul 02nd 2021
] - WOPRAI
[ Fri, Jul 02nd 2021
] - WOPRAI
Thu, July 1, 2021
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
Yun Zhong Downgraded (BLUE) to Hold and Held Target at $35 on, Jul 1st, 2021
Yun Zhong of Berenberg, Downgraded "bluebird bio, Inc." (BLUE) to Hold and Held Target at $35 on, Jul 1st, 2021.
Yun has made no other calls on BLUE in the last 4 months.
There are 3 other peers that have a rating on BLUE. Out of the 3 peers that are also analyzing BLUE, 1 agrees with Yun's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $36 on, Monday, April 19th, 2021
These are the ratings of the 2 analyists that currently disagree with Yun
- Mani Foroohar of "SVB Leerink" Maintained at Buy with Increased Target to $72 on, Monday, March 29th, 2021
- Difei Yang of "Mizuho" Upgraded from Hold to Strong Buy and Increased Target to $69 on, Wednesday, March 10th, 2021
